期刊文献+

吡格列酮辅助治疗2型糖尿病的疗效和安全性分析

下载PDF
导出
摘要 目的探讨吡格列酮辅助治疗2型糖尿病的疗效和安全性分析。方法选取2013年3月—2014年3月于该院接受治疗的30患者,随机分成观察组和对照组。观察组服用吡格列酮30 mg(早饭前),对照组服用二甲双胍(早晚餐前)。比较两组患者服药后第2周后空腹血糖、饭后2 h血糖、糖化血红蛋白、空腹胰岛素含量及饭后2 h胰岛素含量变化情况。结果观察组及对照组用药2周后空腹血糖含量、饭后2 h血糖含量、糖化血红蛋白含量均呈现下降趋势、空腹胰岛素和饭后2 h胰岛素均呈现上升趋势,两组间比较有显著性差异。结论吡格列酮辅助治疗2型糖尿病疗效明显且安全性高,值得临床应用推广。
作者 邹金花 吴斌
机构地区 苏州市中医医院
出处 《糖尿病新世界》 2014年第9X期6-6,共1页 Diabetes New World Magazine
  • 相关文献

参考文献3

二级参考文献19

  • 1Chang YH, Chang DM , Lin KC,et al. Visfatin in overweight/obesi-ty ,type 2 diabetes mellitus, insulin resistance, metabolic syndromeand cardiovascular diseases : a meta-analysis and systemic review[J]. Diabetes Metab Res Rev,2011,27(6) :515 -527. 被引量:1
  • 2Reyes-Soffer G,Rondon-Clavo C ,Ginsberg HN. Combination thera-py with statin and fibrate in patients with dyslipidemia associatedwith insulin resistance,metabolic syndrome and type 2 diabetesmellitus[ J]. Expert Opin Phannacother,2011,12(9) : 1429 - 1438. 被引量:1
  • 3Pappa KI,Gazouli M,Economou K,et al. Gestational diabetes mel-litus shares polymorphisms of genes associated with insulin resist-ance and type 2 diabetes in the Greek population [ J ]. Gynecol En-docrinol,2011,27 (4) :267 -272. 被引量:1
  • 4Gatenby VK,Kearney MT. The role of IGF - 1 resistance in obesityand type 2 diabetes-mellitus-related insulin resistance and vasculardisease[ J]. Expert Opin Ther Targets,2010,14(12) : 1333 - 1342. 被引量:1
  • 5Jorge ML,de Oliveira VN,Resende NM,et al. The effects of aero-bic ,resistance,and combined exercise on metabolic control, in-flammatory markers,adipocytokines,and muscle insulin signalingin patients with type 2 diabetes mellitus [ J ]. Metabolism,2011,60(9):1244 -1252. 被引量:1
  • 6Mehta NN,Krishnamoorthy P,Martin SS,et al. Usefulness of insulinresistance estimation and the metabolic syndrome in predicting coro-nary atherosclerosis in type 2 diabetes mellitus[ J]. Am J Cardiol,2011,107(3) :406 -411. 被引量:1
  • 7Serlie MJ,Allick G,Groener JE,et al. Chronic treatment with piogl-itazone does not protect obese patients with diabetes mellitus type IIfrom free fatty acid-induced insulin resistance [ J ]. J Clin Endocri-nol Metab,2007 ,92(1) :166 -171. 被引量:1
  • 8Namvaran F, Rahimi-Moghaddam P, Azarpira N , et al. Polymorph-ism of adiponectin (45T/G) and adiponectin receptor -2 ( 795G/A) in an Iranian population: relation with insulin resistance and re-sponse to treatment with pioglitazone in patients with type 2 diabetesmellitus[ J]. Mol Biol Rep,2012,39(5) :5511 - 5518. 被引量:1
  • 9Stephens J W,Bodvarsdottir T B , Wareham K,et al. Effects of short-term therapy with glibenclamide and repaglinide on incretin hor-mones and oxidative damage associated with postprandial hypergly-caemia in people with type 2 diabetes mellitus [ J ]. Diabetes ResClin Pract,2011,94(2) :199 -206. 被引量:1
  • 10胡菊萍,陶冬青,张令晖.吡格列酮联用瑞格列奈治疗2型糖尿病的疗效[J].中国药师,2009,12(11):1594-1595. 被引量:6

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部